First day of listing of Syn2bio shares on the regulated market of the WSE
21.05.2026
See also
Synektik shareholders have unanimously approved the division of the company and spinoff of the cardiotracer project to Syn2bio
- Corporate news
- Investor relations
Extraordinary Shareholders’ Meeting on 19 May 2026
- Corporate news
- Investor relations
Synektik edges closer to demerger as Syn2bio files prospectus with KNF
- Corporate news
- Investor relations